QQQ   416.27 (-1.69%)
AAPL   164.62 (-1.45%)
MSFT   398.90 (-1.33%)
META   481.97 (-3.95%)
GOOGL   153.12 (-1.85%)
AMZN   174.66 (-2.54%)
TSLA   148.65 (-0.85%)
NVDA   810.00 (-4.34%)
AMD   148.61 (-4.17%)
NIO   3.82 (-4.50%)
BABA   68.57 (-0.45%)
T   16.33 (+0.00%)
F   12.08 (+0.17%)
MU   106.92 (-4.48%)
GE   148.19 (-3.11%)
CGC   8.02 (+2.43%)
DIS   111.78 (-0.58%)
AMC   3.26 (+11.64%)
PFE   25.77 (+1.50%)
PYPL   61.98 (-0.19%)
XOM   119.94 (+1.20%)
QQQ   416.27 (-1.69%)
AAPL   164.62 (-1.45%)
MSFT   398.90 (-1.33%)
META   481.97 (-3.95%)
GOOGL   153.12 (-1.85%)
AMZN   174.66 (-2.54%)
TSLA   148.65 (-0.85%)
NVDA   810.00 (-4.34%)
AMD   148.61 (-4.17%)
NIO   3.82 (-4.50%)
BABA   68.57 (-0.45%)
T   16.33 (+0.00%)
F   12.08 (+0.17%)
MU   106.92 (-4.48%)
GE   148.19 (-3.11%)
CGC   8.02 (+2.43%)
DIS   111.78 (-0.58%)
AMC   3.26 (+11.64%)
PFE   25.77 (+1.50%)
PYPL   61.98 (-0.19%)
XOM   119.94 (+1.20%)
QQQ   416.27 (-1.69%)
AAPL   164.62 (-1.45%)
MSFT   398.90 (-1.33%)
META   481.97 (-3.95%)
GOOGL   153.12 (-1.85%)
AMZN   174.66 (-2.54%)
TSLA   148.65 (-0.85%)
NVDA   810.00 (-4.34%)
AMD   148.61 (-4.17%)
NIO   3.82 (-4.50%)
BABA   68.57 (-0.45%)
T   16.33 (+0.00%)
F   12.08 (+0.17%)
MU   106.92 (-4.48%)
GE   148.19 (-3.11%)
CGC   8.02 (+2.43%)
DIS   111.78 (-0.58%)
AMC   3.26 (+11.64%)
PFE   25.77 (+1.50%)
PYPL   61.98 (-0.19%)
XOM   119.94 (+1.20%)
QQQ   416.27 (-1.69%)
AAPL   164.62 (-1.45%)
MSFT   398.90 (-1.33%)
META   481.97 (-3.95%)
GOOGL   153.12 (-1.85%)
AMZN   174.66 (-2.54%)
TSLA   148.65 (-0.85%)
NVDA   810.00 (-4.34%)
AMD   148.61 (-4.17%)
NIO   3.82 (-4.50%)
BABA   68.57 (-0.45%)
T   16.33 (+0.00%)
F   12.08 (+0.17%)
MU   106.92 (-4.48%)
GE   148.19 (-3.11%)
CGC   8.02 (+2.43%)
DIS   111.78 (-0.58%)
AMC   3.26 (+11.64%)
PFE   25.77 (+1.50%)
PYPL   61.98 (-0.19%)
XOM   119.94 (+1.20%)
Free Trial
NASDAQ:CHNA

Loncar China Biopharma ETF (CHNA) Price, Holdings, & News

→ Your Next Portfolio Star: Revealing 2024's Top Stock Pick (From Darwin) (Ad)
Free CHNA Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$13.53
▼
$13.53
50-Day Range
$13.53
▼
$14.77
52-Week Range
$13.35
▼
$22.89
Volume
100 shs
Average Volume
538 shs
Market Capitalization
$19.35 million
Assets Under Management
$3.74 million
Dividend Yield
0.44%
Net Expense Ratio
0.79%
Stock AnalysisDividendHeadlinesHoldingsRatingsSocial Media
CHNA stock logo

About Loncar China Biopharma ETF (NASDAQ:CHNA)

The Loncar China BioPharma ETF (CHNA) is an exchange-traded fund that is based on the Loncar China BioPharma index. The fund tracks a tier-weighted index of companies directly involved in the growth of Chinas pharmaceutical and biotech industry. CHNA was launched on Aug 14, 2018 and is managed by Loncar.

CHNA ETF News Headlines

February 6, 2024 | investing.com
MiraeAsset TIGER China Biotech Solactive ETF (371470)
January 20, 2024 | investing.com
China Southern CSI Cmunctn Srvcs ETF (159511)
April 19, 2024 | DTI (Ad)
This company has increased its dividend every year for 54 years
There are three basic steps to building the Ultimate Dividend Portfolio. Step #1 is to Get The High Yields! So an index fund like the SPY, paying only 1.5% a year, isn’t going to cut it. But a company like Altria Group (MO) will.
December 30, 2023 | nasdaq.com
This ETF Has Depth Needed for China Rebound
December 21, 2023 | money.usnews.com
China Bans Export of Rare Earths Processing Technologies
December 19, 2023 | msn.com
China Sinochem Buys Rare Venezuelan Oil Cargo After U.S. Suspends Sanctions - Sources
December 16, 2023 | investing.com
China Universal Nasdaq 100 ETF (QDII) (159660)
December 13, 2023 | investing.com
Amundi MSCI China A II ETF (C024)
April 19, 2024 | TradingTips (Ad)
3 Sub-$10 Stocks to Buy for 2024
Often, investors will overlook stocks just because they're cheap. It's a common thought that a cheap price tag means that something must be wrong with the company. But this couldn't be further from the case in many instances.
December 12, 2023 | investing.com
2823 ETF Stock Price History
See More Headlines
Receive CHNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Loncar China Biopharma ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Exchange Traded Concepts
Fund Name
Loncar China Biopharma ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:CHNA
Inception Date
8/14/2018
Fund Manager
Denise M. Krisko, Habib Moudachirou
Web
N/A
Phone
14089961010

Fund Focus

Asset Class
Equity
Benchmark
Loncar China BioPharma Index
Category
Sector
Focus
Health Care
Development Level
Emerging Markets
Region
Asia-Pacific
Number of Holdings
89

Fund Statistics

Assets Under Management
$3.74 million
Average Daily Volume
$1,200.80
Discount/Premium
-0.06%

Administrator, Advisor and Custodian

Administrator
U.S. Bancorp Fund Services, LLC
Advisor
Exchange Traded Concepts, LLC
Custodian
U.S. Bank, N.A.
Distributor
Quasar Distributors, LLC
Transfer Agent
U.S. Bank, N.A.
Trustee
N/A
Lead Market Maker
GTS

Miscellaneous

Outstanding Shares
280,000
Beta
0.67
Creation Unit
50,000
Creation Fee
$750.00
12 Stocks Corporate Insiders are Abandoning Cover
12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report
Ad DTI
This company has increased its dividend every year for 54 years
There are three basic steps to building the Ultimate Dividend Portfolio. Step #1 is to Get The High Yields! So an index fund like the SPY, paying only 1.5% a year, isn’t going to cut it. But a company like Altria Group (MO) will.
Click here to get them (for Free).

Loncar China Biopharma ETF Expenses

TypeCHNAHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.79%0.56%0.54%0.48%0.51%
Other Expenses0.00%0.40%0.54%0.34%0.58%
Total Expense0.79%0.72%0.70%0.58%0.70%
Fee Waiver0.00%-0.53%-0.55%-0.22%-0.57%
Net Expense0.79%0.60%0.60%0.54%0.58%

Loncar China Biopharma ETF (CHNA) Holdings

Top 10 CHNA Holdings

  • AIM Vaccine Co Ltd Class H
    Holding Weight: 4.27%
  • Legend Biotech(NASDAQ:LEGN)
    Holding Weight: 3.11%
  • Sinopharm Group Co Ltd
    Holding Weight: 2.54%
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H
    Holding Weight: 2.36%
  • Wuxi AppTec Co Ltd
    Holding Weight: 2.24%
  • BeiGene(NASDAQ:BGNE)
    Holding Weight: 2.17%
  • Hansoh Pharmaceutical Group Co Ltd
    Holding Weight: 2.12%
  • Sino Biopharmaceutical Ltd
    Holding Weight: 2.12%
  • Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Class H
    Holding Weight: 2.05%
  • Shanghai Pharmaceuticals Holding Co Ltd Class H
    Holding Weight: 2.04%
Full Holdings Details

CHNA ETF - Frequently Asked Questions

How often does Loncar China Biopharma ETF pay dividends? What is the dividend yield for Loncar China Biopharma ETF?

Loncar China Biopharma ETF announced an annual dividend on Friday, October 13th. Stockholders of record on Tuesday, October 17th will be given a dividend of $0.0674 per share on Wednesday, October 18th. The ex-dividend date of this dividend is Monday, October 16th.
Read our dividend analysis for CHNA.

What does CHNA invest in?

Loncar China Biopharma ETF is a equity fund issued by Exchange Traded Concepts. CHNA focuses on health care investments and follows the Loncar China BioPharma Index. The fund's investments total to approximately $3.74 million assets under management.

What stocks does Loncar China Biopharma ETF hold?

CHNA invests in 89 holdings. Some of the stocks in their portfolio include Geron (GERN), Acrivon Therapeutics (ACRV), Enliven Therapeutics (ELVN), Janux Therapeutics (JANX), Nuvation Bio (NUVB), 2seventy bio (TSVT), Revolution Medicines (RVMD), Prelude Therapeutics (PRLD), Lyell Immunopharma (LYEL) and Adicet Bio (ACET).

What is the management fee for Loncar China Biopharma ETF?

Loncar China Biopharma ETF's management fee is 0.79% and has no other recorded expenses or fee waivers. The net expense ratio for CHNA is 0.79%.

What other stocks do shareholders of Loncar China Biopharma ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Loncar China Biopharma ETF investors own include Baidu (BIDU), Salesforce (CRM), Capcom (CCOEY), Alibaba Group (BABA), Activision Blizzard (ATVI), ArcBest (ARCB), Advanced Micro Devices (AMD) and Analog Devices (ADI).

This page (NASDAQ:CHNA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
Top 5 AI Stocks to Buy for 2024
Market Moving Trends